Last reviewed · How we verify
blood sampling
Blood sampling is a diagnostic procedure that collects blood specimens for laboratory analysis to detect pathogens, assess immune response, or monitor disease markers.
Blood sampling is a diagnostic procedure that collects blood specimens for laboratory analysis to detect pathogens, assess immune response, or monitor disease markers. Used for Detection and monitoring of emerging infectious diseases, Pathogen surveillance and epidemiological tracking.
At a glance
| Generic name | blood sampling |
|---|---|
| Also known as | Blood sampling at Day 0, Day 1 and Day 3, Volumetric absorptive microsampling, temocillin, ceftriaxone, meropenem, Blood chemistry, Tumor sampling |
| Sponsor | ANRS, Emerging Infectious Diseases |
| Modality | Biologic |
| Therapeutic area | Diagnostics / Infectious Disease Surveillance |
| Phase | FDA-approved |
Mechanism of action
Blood sampling involves venipuncture to obtain blood specimens that are analyzed for the presence of infectious agents, antibodies, or other biomarkers relevant to disease diagnosis and monitoring. In the context of ANRS (Agence Nationale de Recherche sur le SIDA) and emerging infectious diseases, blood sampling is used as a diagnostic and surveillance tool rather than a therapeutic intervention. The procedure enables detection and characterization of pathogens and host immune responses.
Approved indications
- Detection and monitoring of emerging infectious diseases
- Pathogen surveillance and epidemiological tracking
Common side effects
- Venipuncture site bruising
- Mild discomfort or pain at collection site
- Vasovagal response (rare)
Key clinical trials
- Collection of Blood From Patients With Prostate Cancer
- Treatment of Hemochromatosis (PHASE2)
- BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia (PHASE2)
- Disorders of the Acute Phase Response Following Trauma and Invasive Surgery (NA)
- Individualized Precision Isavuconazole Therapy Guided by PK/PD Principles for the Geriatric Population
- Epigenetic Regulation of Human Adipose Tissue Distribution (NA)
- Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (PHASE2)
- Food Typologies and Multidimensional Phenotyping of Elderly in Auvergne-Rhône-Alpes (Part'AGE)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- blood sampling CI brief — competitive landscape report
- blood sampling updates RSS · CI watch RSS
- ANRS, Emerging Infectious Diseases portfolio CI